The Pan American Health Organization (PAHO) has launched a groundbreaking initiative to combat the silent killer of high blood pressure and save countless lives. The HEARTS Quality Framework, published in The Lancet Regional Health - Americas, offers a practical roadmap for countries to enhance hypertension management and cardiovascular care. This comprehensive guide aims to prevent heart attacks and strokes, improve primary healthcare, and address the alarming statistics surrounding heart disease and strokes in the Americas.
Heart disease and strokes take the lives of over 2.2 million people annually in the Americas, many of them in their most productive years. High blood pressure, a leading risk factor, affects nearly four out of ten adults in the region. Despite the availability of affordable treatments, only one-third of hypertensive individuals have their condition under control. Dr. Jarbas Barbosa, PAHO Director, emphasizes the urgency, stating that hypertension remains the world's deadliest health threat but is also one of the most manageable.
The HEARTS Quality Framework is a game-changer, translating real-world experiences into a tested blueprint. It addresses critical barriers, such as inaccurate blood pressure measurements due to outdated equipment, limited medicine availability, inconsistent treatment, and unnecessary monthly prescription renewals. This initiative is the largest adaptation of the World Health Organization's (WHO) global HEARTS initiative, currently active in 33 countries, serving nearly 10,000 primary healthcare facilities, and treating over six million people.
The framework's structured model is adaptable to any country's needs, offering concrete strategies. These include mandating reliable, automatic blood pressure monitors, ensuring affordable, quality medicine supply through regional bulk purchasing, enabling multi-month prescriptions, and empowering nurses to adjust medication doses. Simple monthly monitoring tools are also proposed to track performance and facilitate rapid improvements.
The '80-80-80 target' for blood pressure control is a key focus: 80% of diagnosed hypertensive individuals, 80% of those treated, and 80% of treated patients achieving controlled blood pressure. Dr. Pedro Orduñez highlights the potential impact, stating that reaching this goal could prevent over 400,000 deaths and 2.4 million hospitalizations by 2030 in the Americas.
The HEARTS approach has already demonstrated remarkable results. In Cuba, control rates increased from 36% to 58% in a year, and in Chile, from 37% to 65%. The program's cost-effectiveness is evident, as it pays for itself within two years by preventing costly cardiac events. Communities in Colombia, Mexico, Trinidad and Tobago, and others have also seen increased control rates after adopting HEARTS standards.
The Dominican Republic, El Salvador, and Mexico have prioritized HEARTS, providing free treatment and achieving impressive control rates. Dr. Esteban Londoño emphasizes that standardized clinical pathways, reliable medicines, team-based care, and quality-improvement tools can significantly impact millions of lives. The HEARTS Quality Framework is a powerful tool to strengthen hypertension and cardiovascular risk management in primary healthcare, as evidenced by its success across the Americas.
